N/A
Average AnalystN/A
Top AnalystBullish
Stock Target AdvisorN/A
Average UserEUR 21.40
+0.10 (+0.47)%
EUR 0.16B
3.57K
EUR -1.00
Based on the Bastide Le Confort Médical SA stock forecast from 0 analysts, the average analyst target price for Bastide Le Confort Médical SA is not available over the next 12 months. Bastide Le Confort Médical SA’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bastide Le Confort Médical SA is Bullish , which is based on 12 positive signals and 2 negative signals. At the last closing, Bastide Le Confort Médical SA’s stock price was EUR 21.40. Bastide Le Confort Médical SA’s stock price has changed by -4.04% over the past week, +11.57% over the past month and -15.91% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock is trading high compared to its peers median on a price to book value basis.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.